AIDS 2016: A Return to Durban
To be sure, the progress in providing millions of HIV-infected people with life-saving antiretroviral treatment and the progress in developing new prevention strategies was oft discussed at AIDS 2016. But advocates, public health experts, and government officials are far from resting on their laurels. In fact, experts at AIDS 2016 warned that the hard-won gains against HIV/AIDS are in peril of being lost if financial support isn’t maintained and improved HIV prevention efforts aren’t implemented. In this issue, we provide our complete coverage of AIDS 2016. We also look at how the European Union is hoping to stimulate HIV vaccine research efforts across its partner countries and provide an update on the imminent HVTN 702 trial, the first large-scale vaccine efficacy trial to begin since the results of the RV144 trial in Thailand indicated that a prime-boost vaccine regimen provided a modest 31% protection against HIV infection. Finally, we include an interview with Ugandan physician, public health expert, and former IAVI Board member Alex Coutinho about his long and varied career working in HIV.